Background Colorectal cancer screening program using a fecal immunochemical test aims
to reduce morbidity and mortality through early detection. Although screening participation is …

Background: Bowel cancer is the third most commonly diagnosed cancer and the third most
common cause of cancer-related death, with 1,849,518 new cases of bowel diagnosed and …

Introduction: Colorectal cancer (CRC) patients in regional and rural areas tend to be
diagnosed at a more advanced stage than metropolitan patients and have poorer 5-year …

Background Australia has one of the highest incidences of colorectal cancer (CRC)
worldwide. The Australian National Bowel Cancer Screening Program (NBCSP) is a best …

Objectives The aim of the present analysis is to identify the reasons for accepting or rejecting
the invitation to be screened by the Faecal Immunochemical Test as part of the free Danish …

Despite a clear association between the early detection of bowel cancer and increased
survival, participation in mail-out screening programs is poor. Several key barriers to …

Background Increasing participation in the Australian National Bowel Cancer Screening
Program (NBCSP) is the most efficient and cost-effective way of reducing mortality …

Background: In Flanders, the uptake in the population-based colorectal cancer (CRC)
screening program (using fecal immunochemical test, FIT) is suboptimal (~ 50%). This study …

Background General practice plays a critical role in the prevention, diagnosis, management,
and survivorship care of patients with cancer. Mapping research outputs over time provides …

The recommended strategy for population screening in Australia, directed at those at
average risk of colorectal cancer and without relevant symptoms, is immunochemical faecal …